ASCO in Action

ASCO in Action provides the latest news and analysis related to critical policy issues affecting the cancer community, updates on the Association for Clinical Oncology’s ongoing advocacy efforts, and opportunities for members and others in the cancer care community to take action.

To sign up for advocacy alerts, log in to ASCO.org with your member or guest account, and visit the subscription center available under your account profile.

Tune in to the ASCO in Action podcast series for analysis and commentary on cancer policy and practice issues. The podcast is available through iTunes or Google Play.

Showing results for Reimbursement

November 23, 2021

On November 19, 2021, the Build Back Better Act passed the U.S. House of Representatives with a vote of 220-213. The legislation contains significant health care provisions, some of which are outlined here.

November 23, 2021

The Centers for Medicare & Medicaid Services (CMS) is applying the Merit-based Incentive Payment System (MIPS) automatic extreme and uncontrollable circumstances (EUC) policy to all individually eligible MIPS clinicians for the 2021 performance year (PY) due to COVID-19.

November 23, 2021

Due to the ongoing impact of COVID-19, the Centers for Medicare & Medicaid Services (CMS) is allowing clinicians, groups, virtual groups, and Alternative Payment Model (APM) Entities to request MIPS performance category reweighting for PY 2020 under the EUC policy until November 29, 2021. 

November 23, 2021

The Association for Clinical Oncology (ASCO), along with nearly 30 other stakeholder groups, sent a letter to congressional leadership urging lawmakers in both chambers to protect patient access to potentially life-saving cancer care by passing legislation to prevent massive cuts to Medicare reimbursement for radiation oncology.

November 22, 2021

The American Medical Association's House of Delegates recently approved a resolution committing the AMA to strongly advocate against the application of sequestration to Medicare services, including to drugs administered under Medicare Part B, which would result in significant reimbursement cuts for Medicare providers. ASCO strongly advocated for the AMA HOD to pass this resolution.

November 4, 2021

American Society of Clinical Oncology (ASCO) members who are practicing oncologists may have recently received an email inviting them to participate in an American Medical Association’s (AMA) Specialty Society Relative Value Scale (RVS) Update Committee (RUC) survey. This important survey will help ASCO, in collaboration with the RUC, recommend relative value units to the Centers for Medicare & Medicaid Services (CMS) for certain services.  

November 3, 2021

On November 2, 2021, the Centers for Medicare & Medicaid Services (CMS) released the 2022 Hospital Outpatient Prospective Payment System (OPPS) final rule. The Association for Clinical Oncology (ASCO) will analyze the rule in greater detail in the coming days, while initial highlights are outlined here.

November 2, 2021

On November 2, 2021, the Centers for Medicare & Medicaid Services (CMS) released the 2022 Medicare Physician Fee Schedule (PFS) and Quality Payment Program (QPP) final rule. The Association for Clinical Oncology (ASCO) will analyze the rule in greater detail in the coming days, while initial highlights from the rule are outlined here.

September 28, 2021

The American Society of Clinical Oncology’s (ASCO) Coverage and Reimbursement Steering Group presented a poster on utilization of advance care planning (ACP) services at the ASCO Quality Care Symposium.

September 22, 2021

In comments to the Centers for Medicare & Medicaid Services (CMS), the Association for Clinical Oncology (ASCO) expressed significant concerns that several provisions in the 2022 Hospital Outpatient Prospective Payment System (HOPPS) proposed rule have the potential to undermine access to cancer care for Medicare beneficiaries.

September 14, 2021

The Association for Clinical Oncology (ASCO) commented on provisions in the 2022 Medicare Physician Fee Schedule (MPFS) and Quality Payment Program (QPP) proposed rule that would impact cancer care for Medicare beneficiaries. The letter also offers perspective on CMS’ four-stage plan to transition CMS’ quality measurement enterprise to being fully digital by 2025 and how the agency can improve data collection and measurement to help advance health equity in the Medicare program.

September 14, 2021

On September 10, 2021, the Administration announced that the U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), is making $25.5 billion in new funding available for health care providers affected by the COVID-19 pandemic.

September 14, 2021

On September 9, 2021, the Centers for Medicare & Medicaid Services posted new information on reprocessing claims for outpatient clinic visit services provided at excepted off-campus provider-based departments.

August 17, 2021

The American Society of Clinical Oncology and the Association for Clinical Oncology (collectively ASCO) released an in-depth analysis of the impact the 2022 Medicare Physician Fee Schedule (PFS) and Hospital Outpatient Prospective Payment System (OPPS) proposed rules—as well as pending sequestration cuts—could have on cancer care beginning January 1, 2022. 

August 4, 2021

The Centers for Medicare & Medicare Services (CMS) has released Merit-based Incentive Payment System (MIPS) performance feedback and final scores for performance year 2020 and associated MIPS payment adjustment information for payment year 2022.

Pages